1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Biomarker Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Consumables
  • 1.2.3 Service
• 1.3 Market by Application
  • 1.3.1 Global Biomarker Market Share by Application: 2020 VS 2026
  • 1.3.2 Diagnostics Development
  • 1.3.3 Drug Discovery and Development
  • 1.3.4 Disease-Risk
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Biomarker Market Perspective (2015-2026)
• 2.2 Global Biomarker Growth Trends by Regions
  • 2.2.1 Biomarker Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biomarker Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biomarker Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Biomarker Players by Market Size
  • 3.1.1 Global Top Biomarker Players by Revenue (2015-2020)
  • 3.1.2 Global Biomarker Revenue Market Share by Players (2015-2020)
• 3.2 Global Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Biomarker Revenue
• 3.4 Global Biomarker Market Concentration Ratio
  • 3.4.1 Global Biomarker Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Biomarker Revenue in 2019
• 3.5 Key Players Biomarker Area Served
• 3.6 Key Players Biomarker Product Solution and Service
• 3.7 Date of Enter into Biomarker Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Biomarker Breakdown Data by Type (2015-2026)

• 4.1 Global Biomarker Historic Market Size by Type (2015-2020)
• 4.2 Global Biomarker Forecasted Market Size by Type (2021-2026)

5 Biomarker Breakdown Data by Application (2015-2026)

• 5.1 Global Biomarker Historic Market Size by Application (2015-2020)
• 5.2 Global Biomarker Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biomarker Market Size (2015-2026)
• 6.2 North America Biomarker Market Size by Type (2015-2020)
• 6.3 North America Biomarker Market Size by Application (2015-2020)
• 6.4 North America Biomarker Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Biomarker Market Size (2015-2026)
• 7.2 Europe Biomarker Market Size by Type (2015-2020)
• 7.3 Europe Biomarker Market Size by Application (2015-2020)
• 7.4 Europe Biomarker Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Biomarker Market Size (2015-2026)
• 8.2 China Biomarker Market Size by Type (2015-2020)
• 8.3 China Biomarker Market Size by Application (2015-2020)
• 8.4 China Biomarker Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Biomarker Market Size (2015-2026)
• 9.2 Japan Biomarker Market Size by Type (2015-2020)
• 9.3 Japan Biomarker Market Size by Application (2015-2020)
• 9.4 Japan Biomarker Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Biomarker Market Size (2015-2026)
• 10.2 Southeast Asia Biomarker Market Size by Type (2015-2020)
• 10.3 Southeast Asia Biomarker Market Size by Application (2015-2020)
• 10.4 Southeast Asia Biomarker Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 QIAGEN N.V. (Netherlands)
  • 11.1.1 QIAGEN N.V. (Netherlands) Company Details
  • 11.1.2 QIAGEN N.V. (Netherlands) Business Overview
  • 11.1.3 QIAGEN N.V. (Netherlands) Biomarker Introduction
  • 11.1.4 QIAGEN N.V. (Netherlands) Revenue in Biomarker Business (2015-2020))
  • 11.1.5 QIAGEN N.V. (Netherlands) Recent Development
• 11.2 PerkinElmer, Inc. (U.S.)
  • 11.2.1 PerkinElmer, Inc. (U.S.) Company Details
  • 11.2.2 PerkinElmer, Inc. (U.S.) Business Overview
  • 11.2.3 PerkinElmer, Inc. (U.S.) Biomarker Introduction
  • 11.2.4 PerkinElmer, Inc. (U.S.) Revenue in Biomarker Business (2015-2020)
  • 11.2.5 PerkinElmer, Inc. (U.S.) Recent Development
• 11.3 Merck Millipore (U.S.)
  • 11.3.1 Merck Millipore (U.S.) Company Details
  • 11.3.2 Merck Millipore (U.S.) Business Overview
  • 11.3.3 Merck Millipore (U.S.) Biomarker Introduction
  • 11.3.4 Merck Millipore (U.S.) Revenue in Biomarker Business (2015-2020)
  • 11.3.5 Merck Millipore (U.S.) Recent Development
• 11.4 Bio-Rad Laboratories, Inc. (U.S.)
  • 11.4.1 Bio-Rad Laboratories, Inc. (U.S.) Company Details
  • 11.4.2 Bio-Rad Laboratories, Inc. (U.S.) Business Overview
  • 11.4.3 Bio-Rad Laboratories, Inc. (U.S.) Biomarker Introduction
  • 11.4.4 Bio-Rad Laboratories, Inc. (U.S.) Revenue in Biomarker Business (2015-2020)
  • 11.4.5 Bio-Rad Laboratories, Inc. (U.S.) Recent Development
• 11.5 Enzo Biochem, Inc. (U.S.)
  • 11.5.1 Enzo Biochem, Inc. (U.S.) Company Details
  • 11.5.2 Enzo Biochem, Inc. (U.S.) Business Overview
  • 11.5.3 Enzo Biochem, Inc. (U.S.) Biomarker Introduction
  • 11.5.4 Enzo Biochem, Inc. (U.S.) Revenue in Biomarker Business (2015-2020)
  • 11.5.5 Enzo Biochem, Inc. (U.S.) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Biomarker Scope and Market Size
Biomarker market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Consumables
Service

Market segment by Application, split into
Diagnostics Development
Drug Discovery and Development
Disease-Risk

Based on regional and country-level analysis, the Biomarker market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Biomarker market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
QIAGEN N.V. (Netherlands)
PerkinElmer, Inc. (U.S.)
Merck Millipore (U.S.)
Bio-Rad Laboratories, Inc. (U.S.)
Enzo Biochem, Inc. (U.S.)
...